Vivani Medical, Inc. Common Stock (DE)
VANIStock
$1.35−7.24%52W
Market Cap$121.59M
P/E—
Div yield—
Beta2.41
Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-0.16%
Price vs S&P 500 (4W)19.92%
VGM Score59.82
Market Capitalization$121.59M
Earnings Surprise History
Q1 26-0.08est. -0.08
Analyst Recommendations
Apr 2026
May 2026
Jun 2026
Jul 2026
4.11
4.11
4.11
4.10
Industry Peers — Electromedical Equipment(32)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
VANIVivani Medical, Inc. Common Stock (DE) | — | — | C | $1.35 |
| MDTMedtronic plc | B | C | C | $83.56 |
| MASIMasimo Corporation | D | D | C | $179.95 |
| LIVNLivaNova PLC Ordinary Shares | C | C | B | $81.79 |
| ITGRInteger Holdings Corporation | B | C | B | $99.62 |
| TMDXTransMedics Group, Inc. Common Stock | C | B | D | $76.00 |
| AXGNAxogen, Inc. Common Stock | F | B | B | $39.77 |
| BLFSBioLife Solutions Inc. | F | B | A | $30.26 |
| CNMDCONMED Corporation | A | C | B | $45.01 |
| INMDInMode Ltd. Ordinary Shares | A | D | B | $15.60 |
| CBLLCeriBell, Inc. Common Stock | D | A | C | $19.14 |
About
Vivani Medical is a clinical-stage biopharmaceutical company developing miniature subdermal implants using proprietary NanoPortal technology to deliver medications for chronic diseases with once or twice-yearly dosing. The platform addresses a critical market need by enabling long-term, consistent drug delivery to improve medication adherence. Its flagship candidates focus on GLP-1 delivery, competing in the rapidly growing metabolic disease market alongside established drugs like Ozempic and Wegovy.